BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

More documents

Recommendations

Info

Russell, M. L. and Ferguson, C. A. Using epidemiology to target staff influenza vaccination programs Infect.Control Hosp.Epidemiol. 2001, 22 (8): 525526. Russell, M. L. Influenza vaccination in Alberta longterm care facilities CMAJ. 5152001, 164 (10): 14231427. Ryan, E. J., Daly, L. M., and Mills, K. H. Immunomodulators and delivery systems for vaccination by mucosal routes Trends Biotechnol. 2001, 19 (8): 293 304. Saadoun D, Cacoub P, Mahoux D, Sbai A, Piette JC. Postvaccine vasculitis: a report of three cases. Rev Med Interne 2001 Feb;22(2):1726. Saha, S. K., Baqui, A. H., Hanif, M., Darmstadt, G. L., Ruhulamin, M., Nagatake, T., Santosham, M., and Black, R. E. Typhoid fever in Bangladesh: implications for vaccination policy Pediatr.Infect.Dis.J. 2001, 20 (5): 521524. Salleras, L., Dominguez, A., Prats, G., Parron, I., and Munoz, P. Dramatic decline of serogroup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people J.Epidemiol.Community Health. 2001, 55 (4): 283287. Salmon <strong>DA</strong>, Siegel AW. Religious and philosophical exemptions from vaccination requirements and lessonslearned from conscientious objectors from conscription. Public Health Rep. 2001 JulAug;116(4):28995. Sasmaz, R., Altinyazar, H. C., Tatlican, S., Eskioglu, F., and Yurtsever, P. Recurrent lupus vulgaris following repeated BCG (Bacillus Calmette Guerin) vaccination J.Dermatol. 2001, 28 (12): 762764. Schaberg, T. [Protective Vaccination Against Pneumococci]. Pneumologie 2001; 55(12): 543545. Schellenberg, D., Menendez, C., Kahigwa, E., Aponte, J., Vidal, J., Tanner, M., Mshinda, H., and Alonso, P. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebocontrolled trial Lancet. 5122001, 357 (9267): 14711477. Schmitt, H. J. and Habermehl, P. [Your most important duty concerning vaccinations in childhood. Instruct the parents!] MMW.Fortschr.Med. 11152001, 143 (46): 3639. Schneider, E. C., Cleary, P. D., Zaslavsky, A. M., and Epstein, A. M. Racial Disparity in Influenza Vaccination: Does Managed Care Narrow the Gap Between African Americans and Whites? JAMA. 9262001, 286 (12): 14551460. Schnorr JJ, Cutts FT, Wheeler JG, Akramuzzaman SM, Alam MS, Azim T, SchneiderSchaulies S, terMeulen V. Immune modulation after measles vaccination of 69 months old Bangladeshi infants. Vaccine 2001 Jan 8;19(1112):150310. Schofield I. Influenza vaccination. Nurs Older People. 2000 Dec2001 Jan;12(9):214; quiz 25. School absenteeism, parental work loss, and acceptance of childhood influenza vaccination Am.J.Med.Sci. 2001, 321 (3): 178180. Schunk, M., Wachinger, W., and Wachinger, H. Vaccination status and prophylactic measures of travelers from Germany to subtropical and tropical areas: results of an airport survey J.Travel.Med. 2001, 8 (5): 260262. Schwartz M, Kipnis J. Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol Med 2001 Jun;7(6):2528. Schwartz, B. and Orenstein, W. A. Vaccination Policies and Programs: The Federal Government's Role in Making the System Work. Prim Care 2001; 28(4): 697711. Scrimgeour, E. M. and Mehta, F. R. Rabies in Oman: failed postexposure vaccination in a lactating woman bitten by a fox. Int J Infect Dis 2001; 5(3): 1602. Sen S, Cloete Y, Hassan K, Buss P. Adverse events following vaccination in premature infants. Acta Paediatr 2001 Aug;90(8):91620. Sen, S., Cloete, Y., Hassan, K., and Buss, P. Adverse events following vaccination in premature infants Acta Paediatr. 2001, 90 (8): 916920. Shadick, N. A., Liang, M. H., Phillips, C. B., Fossel, K., and Kuntz, K. M. The Costeffectiveness of Vaccination Against Lyme Disease Arch.Intern.Med. 2 262001, 161 (4): 554561. Shah, S., Raman, S., Moreira, C., and MacIntyre, C. R. School immunisation certificatesa review over time in a disadvantaged community Aust.N.Z.J.Public Health. 2001, 25 (6): 534538. Shefer, A. M., Luman, E. T., Lyons, B. H., Coronado, V. G., Smith, P. J., Stevenson, J. M., and Rodewald, L. E. Vaccination status of children in the Women, Infants, and Children (WIC) Program(2). Are we doing enough to improve coverage? Am.J.Prev.Med. 2001, 20 (4 Suppl): 4754. Silverman, N. S. and Greif, A. Influenza vaccination during pregnancy. Patients' and physicians' attitudes J.Reprod.Med. 2001, 46 (11): 989994. Simonsen, L., Morens, D., Elixhauser, A., Gerber, M., Van Raden, M., and Blackwelder, W. Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception Lancet. 10132001, 358 (9289): 12241229. Singh, D., Sutton, C., and Woodcock, A. Repeat Tuberculin Testing in BCGvaccinated Subjects in the United Kingdom. The booster effect varies with the time of reading Am.J.Respir.Crit Care Med. 9152001, 164 (6): 962964. Sinisalo, M., Aittoniemi, J., Oivanen, P., Kayhty, H., Olander, R. M., and Vilpo, J. Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia Br.J.Haematol. 2001, 114 (1): 107110. Skull, S. A. and Butler, J. R. Meningococcal vaccination for adolescents? An economic evaluation in Victoria J.Paediatr.Child Health. 2001, 37 (5): S28S33. Skull, S. A. and Wang, E. E. Varicella vaccinationa critical review of the evidence Arch.Dis.Child. 2001, 85 (2): 8390. Skull, S. A., Andrews, R. M., Gorrie, G. J., Riddell, M. A., and Street, A. C. Healthcare workers continue to be at risk of measles: a case for better vaccination coverage Med.J.Aust. 6182001, 174 (12): 662663. Skull, S. and Butler, J. Meningococcal vaccination for adolescents? An economic evaluation in Victoria. J Paediatr Child Health 2001; 37(5): 2833. Skull, S., Butler, J., Robinson, P., and Carnie, J. Should programmes for communitylevel meningococcal vaccination be considered in Australia? An economic evaluation Int.J.Epidemiol. 2001, 30 (3): 571578. Slee DS, Lagro SW, Frenkel J. Acute hemorrhagic edema in children: excellentprognosis. Ned Tijdschr Geneeskd 2001 Apr 28;145(17):8304. Sleeman K, Knox K, Ge<strong>org</strong>e R, Miller E, Waight P, Griffiths D, Efstratiou A, Broughton K, MayonWhite RT, Moxon ER, et al. Invasive Pneumococcal Disease in England and Wales: Vaccination Implications. J Infect Dis 2001 Jan;183(2):23946 Smeeth, L., Hall, A. J., Fombonne, E., Rodrigues, L. C., Huang, X., and Smith, P. G. A casecontrol study of autism and mumpsmeaslesrubella vaccination using the general practice research database: design and methodology BMC.Public Health. 2001, 1 (1): 2. Sparkes, A. H. Towards a more rational and scientific approach to vaccination J.Feline.Med.Surg. 2001, 3 (2): 4546. Stambos V, Brussen KA, Turnbull A, Thorley B, Kennett M. Report of the Australian National Polio Reference Laboratory, 1 July to 31 December 2000. Commun Dis Intell 2001 Apr;25(2):548. Stephenson, J. The World in Medicine: Smallpox Vaccination and the WHO JAMA. 11142001, 286 (18): 2225. StevensJohnson Syndrome After Vaccination. Pediatr Infect Dis J 2001; 20(8): 818819. Stokley S, Rodewald LE, Maes EF. The impact of record scattering on the measurement of immunization coverage. Pediatrics 2001 Jan;107(1):916 Stokley, S., Smith, P. J., Klevens, R. M., and Battaglia, M. P. Vaccination status of children living in rural areas in the United States(2). Are they protected? Am.J.Prev.Med. 2001, 20 (4 Suppl): 5560. Strauss, B. and Bigham, M. Does measlesmumpsrubella (MMR) vaccination cause inflammatory bowel disease and autism? Can.Commun.Dis.Rep. 415 2001, 27 (8): 6572. Suker, J. and Feavers, I. M. Prospects offered by genome studies for combating meningococcal disease by vaccination Pharmacogenomics. 2001, 2 (3): 273 283. Swan, R. Public health risks of not vaccinating children JAMA. 3282001, 285 (12): 15731574. Takao, S., Ishida, T., Shimazu, Y., Fukuda, S., Noda, M., and Miyazaki, K. Genetic differentiation of a measles virus isolated from a case occurring 15 days after measles vaccination Jpn.J.Infect.Dis. 2001, 54 (3): 119120. Talani, P., Nzaba, P., Bolanda, D., Ambedet, A., and Moyen, G. [Antitetanus vaccination protection on the Kouilou region of CongoBrazzaville] Med.Trop.(Mars.). 2001, 61 (2): 195. Tantawichien, T., Tantawichien, T., Supit, C., Khawplod, P., and Sitprija, V. Threeyear experience with 4site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis Clin.Infect.Dis. 12152001, 33 (12): 20852087.
Taranger, J., Trollfors, B., Bergfors, E., Knutsson, N., Lagergard, T., Schneerson, R., and Robbins, J. B. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. Pediatrics 2001; 108(6): 115. Taranger, J., Trollfors, B., Bergfors, E., Knutsson, N., Sundh, V., Lagergard, T., LindBrandberg, L., Zackrisson, G., White, J., Cicirello, H., Fusco, J., and Robbins, J. B. Mass vaccination of children with pertussis toxoiddecreased incidence in both vaccinated and nonvaccinated persons Clin.Infect.Dis. 101 2001, 33 (7): 10041010. Tillmann, B. U., Tillmann, H. C., Nars, P. W., and Weber, P. Vaccination rate and age of premature infants weighing
Page 1 and 2: BIBLIOGRAFIA SUI DANNI DA VACCINI A
Page 3 and 4: Alter HJ, Scanlon RT, Schechter GP.
Page 5 and 6: Cherry, JD, et al. A Clinical and S
Page 7 and 8: Kazarian EL, Gager WE. Optic neurit
Page 9 and 10: Coplan J. Seizures following immuni
Page 11 and 12: Ipp MM, Gold R, Greenberg S, Goldba
Page 13 and 14: Int J Ped Oto, Feb 1998, 43(1):73
Page 15 and 16: Mashikian MV, Stollerman GH. Vaccin
Page 17 and 18: Wu T, Wang SL, Xiang YZ. Study on t
Page 19 and 20: Prevots DR, Ciofi degli Atti ML, Sa
Page 21 and 22: Del Giudice G, Pizza M, Rappuoli R.
Page 23 and 24: Huber S, Kappos L, Fuhr P, Wetzel S
Page 25 and 26: Ngui SL, Hallet R, Teo CG. Natural
Page 27 and 28: Thomson J, Hilditch A, Pirkis J, Du
Page 29 and 30: Belloni C, Pistorio A, Tinelli C, K
Page 31 and 32: DanielRibeiro CT. Is there a role
Page 33 and 34: Gallup, R. The MMR question [letter
Page 35 and 36: Hull BP, McIntyre PB. A reevaluat
Page 37 and 38: Lieu TA, Ray GT, Black SB, Butler J
Page 39 and 40: Mulholland K. Evaluation of vaccine
Page 41 and 42: Rudolph, K. M., Parkinson, A. J., R
Page 43 and 44: Taylor JA, Newman RD. Parental atti
Page 45 and 46: Bonaccorsi G, Papini D, Bonanni P,
Page 47 and 48: Hanna, J. N., Young, D. M., Brookes
Page 49: Mortimer, E. A. Jr, Ball, R., Ball,
Page 53 and 54: Christensen, L. S., Scholler, S., S
Page 55 and 56: Khanal, P. Nepal's Childhood Mortal
Page 57 and 58: Poland GA, Jacobson RM, Vierkant RA
Page 59 and 60: Vyse, A. J., Gay, N. J., White, J.
Page 61 and 62: Brodkin, H. Economic Analysis of In
Page 63 and 64: Freed, G. L., Davis, M. M., and Cla
Page 65 and 66: Karlsen, T. H.; Sommerfelt, H.; Klo
Page 67 and 68: NascimentoCarvalho, C. M.; Moreno
Page 69 and 70: Skegg, D. C. Autism and MeaslesMu
Page 71 and 72: Wharton, M., Strikas, R. A., Harpaz
Page 73 and 74: Boyce, T. G.; Weaver, A. L.; St Sau
Page 75 and 76: D'Heilly, S. J.; Nichol, K. L. Work
Page 77 and 78: Guy, B.; Chanthavanich, P.; Gimenez
Page 79 and 80: Koca, R.; Altinyazar, H. C.; Numano
Page 81 and 82: Modlin, J. F. Poliomyelitis in the
Page 83 and 84: Roost, H. P.; Gassner, M.; Grize, L
Page 85 and 86: Vazquez, M.; LaRussa, P. S.; Gersho
Page 87 and 88: Beaujean, D. J.; Verweij, M. F.; va
Page 89 and 90: Desjeux, G.; GaloisyGuibal, L.; C
Page 91 and 92: Gust, D.; Brown, C.; Sheedy, K.; Hi
Page 93 and 94: Koch, D.; Thompson, L.; Swart, B. L
Page 95 and 96: Newport, M. J.; Goetghebuer, T.; Ma
Page 97 and 98: Satcher, D. Adult Immunization Disp
Page 99 and 100: Timmermans, D. R.; Henneman, L.; Hi
Page 101 and 102:
Aaby, P.; Jensen, H.; Walraven, G.
Page 103 and 104:
Carrat, F.; Lavenu, A.; Cauchemez,
Page 105 and 106:
Emanuel, E. J.; Wertheimer, A. Publ
Page 107 and 108:
Halperin, S. A.; Sweet, L.; Baxenda
Page 109 and 110:
Klote, M. M.; Engler, R. J.; Martin
Page 111 and 112:
Mitka, M. Age Range Widens for Pert
Page 113 and 114:
Pool, V.; Iskander, J. Safety of In
Page 115 and 116:
Skowronski, D. M.; Woolcott, J. C.;
Page 117 and 118:
Vu, D. M.; Kelly, D.; Heath, P. T.;
Page 119 and 120:
Approved: New Requirement Allowing
Page 121 and 122:
Caldwell, S. J.; Hayney, M. S. Prop
Page 123 and 124:
Dempsey, A. F. Vaccination Against
Page 125 and 126:
Galvani, A. P.; Reluga, T. C.; Chap
Page 127 and 128:
Influenza Vaccination Coverage Amon
Page 129 and 130:
Lawrence, S. J.; Lottenbach, K. R.;
Page 131 and 132:
Monath, T. P. Yellow Fever As an En
Page 133 and 134:
Patrick, D. Prevention Strategies:
Page 135 and 136:
Scheiblhofer, S.; Weiss, R.; Thalha
Page 137 and 138:
Takada, T.; Yamashita, T.; Sato, M.
Page 139 and 140:
Winston, C. A.; Mims, A. D.; Leathe
Page 141 and 142:
Bechtol, Z. Launching a Community
Page 143 and 144:
Chumakov, K.; Ehrenfeld, E. Vaccine
Page 145 and 146:
Dylag, A. M.; Shah, S. I. Administr
Page 147 and 148:
GomezdeLeon, P.; DiazGarcia,
Page 149 and 150:
Jackson, L. A.; Starkovich, P.; Dun
Page 151 and 152:
Kusuhara, K.; Ohga, S.; Hoshina, T.
Page 153 and 154:
Madjid, M. Acute Infections, Vaccin
Page 155 and 156:
Naghipour, M.; Nakagomi, T.; Nakago
Page 157 and 158:
Pool, R.; Mushi, A.; Armstrong, Sch
Page 159 and 160:
Savidan, E.; Chevat, C.; Marsh, G.
Page 161 and 162:
Strauman, T. J.; Coe, C. L.; McCrud
Page 163 and 164:
Vien, N. C.; Feroldi, E.; Lang, J.
Page 165 and 166:
Akmatov, M. K.; Mikolajczyk, R. T.;
Page 167 and 168:
Braillon, A. A New French Paradox:
Page 169 and 170:
Daley, M. F.; Curtis, C. R.; Pyrzan
Page 171 and 172:
Flu Campaign Receives Excellence Aw
Page 173 and 174:
Holvast, A.; van, Assen S.; de, Haa
Page 175 and 176:
Kisakye, A.; Makumbi, I.; Nansera,
Page 177 and 178:
Makidon, P. E.; Nigavekar, S. S.; B
Page 179 and 180:
Niu, M.; Ball, R. Adverse Events Af
Page 181 and 182:
Primus, L. Improving Influenza Vacc
Page 183 and 184:
Schwartz, B.; Orenstein, W. A. Prio
Page 185 and 186:
Tharmaphornpilas, P.; Yoocharean, P
Page 187 and 188:
Weiskopf, D.; Weinberger, B.; Grube
show all

BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

Create successful ePaper yourself

Delete template?

Save as template?